Suppr超能文献

开发用于注意力缺陷/多动障碍和情绪失调儿童的综合主要结局评分。

Development of a Composite Primary Outcome Score for Children with Attention-Deficit/Hyperactivity Disorder and Emotional Dysregulation.

机构信息

Helfgott Research Institute, National University of Natural Medicine, Portland, Oregon.

Department of Child and Adolescent Psychiatry, Oregon Health & Science University, Portland, Oregon.

出版信息

J Child Adolesc Psychopharmacol. 2020 Apr;30(3):166-172. doi: 10.1089/cap.2019.0179. Epub 2020 Feb 26.

Abstract

Study goals were to (1) provide a rationale for developing a composite primary outcome score that includes symptom severity for attention-deficit/hyperactivity disorder (ADHD) and emotional dysregulation, plus symptom-induced impairment; (2) demonstrate weighting methods to calculate the composite score using a sample of children diagnosed with ADHD and aggression; and (3) identify the optimal weighting method most sensitive to change, as measured by effect sizes. We conducted secondary data analyses from the previously conducted Treatment of Severe Childhood Aggression (TOSCA) study. Children aged 6-12 years were recruited through academic medical centers or community referrals. The composite primary outcome comprised the ADHD, oppositional defiant disorder, disruptive mood dysregulation disorder, and peer conflict subscales from the Child and Adolescent Symptom Inventory (CASI), a DSM ()-referenced rating scale of symptom severity and symptom-induced impairment. Five weighting methods were tested based on input from senior statisticians. The composite score demonstrated a larger (Cohen's ) effect size than the individual CASI subscales, irrespective of the weighting method (10%-55% larger). Across all weighting methods, effect sizes were similar and substantial: approximately a two-standard deviation symptom reduction (range: -1.97 to -2.04), highest for equal item and equal subscale weighting, was demonstrated, from baseline to week 9, among all TOSCA participants. The composite score showed a medium positive correlation with the Clinical Global Impressions-Severity scores, 0.46-0.47 for all weighting methods. A composite score that included severity and impairment ratings of ADHD and emotional dysregulation demonstrated a more robust pre-post change than individual subscales. This composite may be a more useful indicator of clinically relevant improvement in heterogeneous samples with ADHD than single subscales, avoiding some of the statistical limitations associated with multiple comparisons. Among the five similar weighting methods, the two best appear to be the equal item and equal subscale weighting methods.

摘要

研究目的是

(1)为开发一个包含注意力缺陷/多动障碍(ADHD)和情绪失调症状严重程度以及症状引起的损害的综合主要结局评分提供依据;(2)使用诊断为 ADHD 和攻击性的儿童样本展示计算综合评分的加权方法;(3)通过效应大小确定最敏感于变化的最佳加权方法。我们对先前进行的儿童严重攻击行为治疗(TOSCA)研究进行了二次数据分析。6-12 岁的儿童通过学术医疗中心或社区推荐招募。综合主要结局由儿童和青少年症状清单(CASI)的 ADHD、对立违抗性障碍、破坏性情绪失调障碍和同伴冲突子量表组成,CASI 是一种 DSM()参考的症状严重程度和症状引起的损害评定量表。基于资深统计学家的意见,测试了五种加权方法。综合评分比个体 CASI 子量表表现出更大的(Cohen's )效应量,而不论加权方法如何(大 10%-55%)。在所有加权方法中,效应量相似且较大:大约有两标准差的症状减轻(范围:-1.97 至-2.04),从基线到第 9 周,所有 TOSCA 参与者均显示出最高的等项目和等子量表加权方法。综合评分与临床总体印象严重程度评分呈中度正相关,所有加权方法的相关系数为 0.46-0.47。与单个子量表相比,包含 ADHD 和情绪失调严重程度和损害评分的综合评分显示出更强大的前后变化。这种综合评分可能是具有 ADHD 的异质样本中更有用的临床相关改善指标,避免了与多次比较相关的一些统计限制。在五种相似的加权方法中,前两种似乎是等项目和等子量表加权方法。

相似文献

1
Development of a Composite Primary Outcome Score for Children with Attention-Deficit/Hyperactivity Disorder and Emotional Dysregulation.
J Child Adolesc Psychopharmacol. 2020 Apr;30(3):166-172. doi: 10.1089/cap.2019.0179. Epub 2020 Feb 26.
4
[Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?].
Encephale. 2015 Apr;41(2):108-14. doi: 10.1016/j.encep.2013.12.004. Epub 2014 Apr 1.
5
Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Cochrane Database Syst Rev. 2012 Sep 12(9):CD008559. doi: 10.1002/14651858.CD008559.pub2.
6
Treatment Efficacy of Internet Gaming Disorder With Attention Deficit Hyperactivity Disorder and Emotional Dysregulaton.
Int J Neuropsychopharmacol. 2020 Jun 24;23(6):349-355. doi: 10.1093/ijnp/pyaa010.
8
Comorbid symptom severity in attention-deficit/hyperactivity disorder: a clinical study.
J Clin Psychiatry. 2012 May;73(5):711-7. doi: 10.4088/JCP.11m07099.
9
Disruptive Mood Dysregulation Disorder Symptoms and Association with Oppositional Defiant and Other Disorders in a General Population Child Sample.
J Child Adolesc Psychopharmacol. 2016 Mar;26(2):101-6. doi: 10.1089/cap.2015.0074. Epub 2016 Jan 8.

引用本文的文献

1
Annual Research Review: Micronutrients and their role in the treatment of paediatric mental illness.
J Child Psychol Psychiatry. 2025 Apr;66(4):477-497. doi: 10.1111/jcpp.14091. Epub 2024 Dec 20.
2
Short-term effects of an elimination diet and healthy diet in children with attention-deficit/hyperactivity disorder: a randomized-controlled trial.
Eur Child Adolesc Psychiatry. 2024 May;33(5):1503-1516. doi: 10.1007/s00787-023-02256-y. Epub 2023 Jul 11.
3
Micronutrients for ADHD in youth (MADDY) study: comparison of results from RCT and open label extension.
Eur Child Adolesc Psychiatry. 2024 May;33(5):1355-1367. doi: 10.1007/s00787-023-02236-2. Epub 2023 Jun 8.
5
Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial.
J Am Acad Child Adolesc Psychiatry. 2022 May;61(5):647-661. doi: 10.1016/j.jaac.2021.07.005. Epub 2021 Jul 22.
6
Diagnostic instruments for the assessment of disruptive mood dysregulation disorder: a systematic review of the literature.
Eur Child Adolesc Psychiatry. 2023 Jan;32(1):17-39. doi: 10.1007/s00787-021-01840-4. Epub 2021 Jul 7.
7
Relationship between stressful life events, coping styles, and schizophrenia relapse.
Int J Ment Health Nurs. 2021 Oct;30(5):1149-1159. doi: 10.1111/inm.12865. Epub 2021 May 6.

本文引用的文献

2
Evaluating chronic emotional dysregulation and irritability in relation to ADHD and depression genetic risk in children with ADHD.
J Child Psychol Psychiatry. 2020 Feb;61(2):205-214. doi: 10.1111/jcpp.13132. Epub 2019 Oct 12.
6
Pharmacotherapy of emotional dysregulation in adults with ADHD: A systematic review and meta-analysis.
Neurosci Biobehav Rev. 2018 Jan;84:359-367. doi: 10.1016/j.neubiorev.2017.08.010. Epub 2017 Aug 26.
8
Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.
Pediatrics. 2015 Apr;135(4):e994-1001. doi: 10.1542/peds.2014-3482. Epub 2015 Mar 2.
9
Treatment of children with attention-deficit/hyperactivity disorder (ADHD) and irritability: results from the multimodal treatment study of children with ADHD (MTA).
J Am Acad Child Adolesc Psychiatry. 2015 Jan;54(1):62-70.e3. doi: 10.1016/j.jaac.2014.10.006. Epub 2014 Oct 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验